Brilliant Cresyl Blue (BCB) Stain (Methylene Blue)

Introduction

Brilliant Cresyl Blue (BCB) or new methylene blue (NMB) stains are also known as supravital stains. These stains are commonly used to stain reticulocytes, Heinz bodies  or H inclusions. Enumeration of reticulocytes is a simple technique to assess bone marrow activity in producing red blood cells. Higher reticulocyte count compared to normal infers a high erythropoietic activity in the bone marrow. Commonly, reticulocytosis occurs following acute blood loss or hemolysis,  in chronic anemias or also in response to treatment with recombinant erythropoietin. 

Principle of BCB

Reticulocytes are immature red blood cells that still contain ribosomal RNA. On exposure to the BCB stain, the ribosomes in the reticulocytes precipitate to form reticulin  and appear like a reticular mesh that stains purple while the cytoplasms stain a pale greenish blue. 

Method differs slightly according to the manufacturer’s protocol. 

Materials

  • 1 g of BCB is dissolved in 100 mL of 0.9% saline containing 0.4 g sodium citrate
  • 1 mL of EDTA peripheral blood
  • 1 glass test tube (10 m x 75 mm)
  • Pasteur pipette
  • Dry incubator set at 37oC
  • Hair dryer
  • A clean glass slide

Protocol

  1. Centrifuge the peripheral blood in the test tube at 1006 g for 5 minutes. 
  2. Remove the plasma completely using a Pasteur pipette, leaving only the packed red cell in the tube.
  3. Resuspend the packed red cells by gently flicking the bottom of the test tube.
  4. Add an equal volume of BCB or NMB stain. 
  5. Gently mix the contents and incubate for 15 minutes at 37oC. 
  6. After incubation, resuspend the contents of the tube using a Pasteur pipette and use 1 drop of the mixture to make a thin smear on a clean glass slide. 
  7. Dry the slide using the hair dryer on the lowest speed or air dry in a tilted position.
  8. This slide is now ready for viewing using oil immersion under a high power (X100) lens. 

*After 15 minutes of incubation time, reticulin and Heinz bodies will be visible. Heinz bodies will stain dark blue-purple. However, further incubation time for approximately 2 hours is required if H inclusions are required for confirmation. H inclusions will appear like dark blue golf balls within the red blood cells. Please note that the H inclusion test cannot be performed on a stored sample. 

Interpretation

Reticulocytes can be visualized using the BCB stain
Reticulocytes in Peripheral Blood (supravital stain)” by euthman is licensed under CC BY 2.0.

The normal reference range for reticulocytes count in a normal adult is 35 – 108 x 109/L (0.5 – 2.1%). In infants whether full term or using cord blood the range is 2 – 5%.

Disclaimer: This protocol is intended for informational purposes only and may need to be modified depending on the specific laboratory procedures and patient circumstances. Always consult with a qualified healthcare professional for guidance. See additional information.

References

  1. Bain BJ. A Practical Guide. 6th Edition (Wiley). 2022.
  2. Bain BJ, Bates I, Laffan MA. Dacie and Lewis Practical Haematology: Expert Consult: Online and Print 12th Edition (Elsevier). 2016.
  3. Carr JH. Clinical Hematology Atlas 6th Edition (Elsevier). 2021.

Related Diseases

Interpretation of Antibody Identification Antigram

Interpretation of Antibody Identification Antigram

Introduction Blood transfusions are life-saving medical procedures, but incompatible blood types can lead to severe and potentially fatal reactions. To ensure safety, we rely on a meticulous process of antibody identification, and a key tool in this process is the...

Antibody Identification

Antibody Identification

Introduction A key component of pre-transfusion testing is antibody identification (ABID). This procedure identifies clinically significant antibodies present in the recipient's plasma or serum that can react with antigens on donor red blood cells (RBCs). These...

Antibody Screening

Antibody Screening

Introduction  Antibody screening, a cornerstone of blood transfusion safety, aims to detect clinically significant unexpected red blood cell (RBC) antibodies in a patient's plasma or serum. These antibodies can develop through various mechanisms, including prior...